scholarly journals Irritable bowel syndrome: an integrated explanatory model for clinical practice

2015 ◽  
Vol 27 (6) ◽  
pp. 750-763 ◽  
Author(s):  
A. P. S. Hungin ◽  
A. Becher ◽  
B. Cayley ◽  
J. J. Heidelbaugh ◽  
J. W. M. Muris ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Explanatory Model ◽  
Irritable Bowel

PWE-241 Management of irritable bowel syndrome in UK clinical practice

Gut ◽  
2015 ◽  
Vol 64 (Suppl 1) ◽  
pp. A318.1-A318
Author(s):  
I Caldwell ◽  
J Collins ◽  
RM Dew ◽  
M Rance
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Irritable Bowel

Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome

2015 ◽  
Vol 50 (7) ◽  
pp. 817-818
Author(s):  
Shin Fukudo ◽  
Hiroshi Kaneko ◽  
Hirotada Akiho ◽  
Masahiko Inamori ◽  
Yuka Endo ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Clinical Practice Guideline ◽  
Practice Guideline ◽  
Kampo Medicine ◽  
Irritable Bowel

scholarly journals Evidence-based clinical practice guidelines for irritable bowel syndrome

2014 ◽  
Vol 50 (1) ◽  
pp. 11-30 ◽  
Author(s):  
Shin Fukudo ◽  
Hiroshi Kaneko ◽  
Hirotada Akiho ◽  
Masahiko Inamori ◽  
Yuka Endo ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Evidence Based ◽  
Irritable Bowel

scholarly journals “Gastrointestinal” comorbidity in irritable bowel syndrome

2021 ◽  
Vol 1 (6) ◽  
pp. 104-111
Author(s):  
O. V. Gaus ◽  
M. A. Livzan
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Practice ◽  
Characteristic Feature ◽  
Overlap Syndrome ◽  
Diagnosis And Treatment ◽  
Urgent Problem ◽  
Functional Disorders ◽  
Modern Information ◽  
Irritable Bowel ◽  
Real Clinical Practice

Among the large and heterogeneous group of patients with irritable bowel syndrome (IBS) comorbidity is characteristic feature. Comorbidity is an urgent problem in real clinical practice. Gastrointestinal comorbidity of a patient with IBS is associated with the presence of common pathogenetic links and is represented by combined pathology with functional disorders and the formation of “overlap syndrome” with organic diseases. Often, with a comorbid course, the phenomenon of “mutual burdening” is observed, when the severity of the course of each of them increases. All this requires optimization of approaches to the diagnosis and treatment of this cohort of patients. Obviously, with a comorbid course of IBS, it is advisable to prescribe drugs that affect the general links of pathogenesis, rather than focusing on individual symptoms. This article presents modern information on the gastrointestinal comorbidity of a patient with IBS.

scholarly journals RIFAXIMIN INDUCED HYPONATREMIA: A CASE REPORT

2016 ◽  
Vol 9 (9) ◽  
pp. 1 ◽  
Author(s):  
Shalini Upadhyay ◽  
Prabhat Agrawal ◽  
Manish Bansal ◽  
Anjalika Gupta
Keyword(s):  
Irritable Bowel Syndrome ◽  
Case Report ◽  
Clinical Practice ◽  
Side Effects ◽  
Side Effect ◽  
Aged Woman ◽  
Rare Side Effect ◽  
Middle Aged Woman ◽  
The Common ◽  
Irritable Bowel

ABSTRACTRifaximin is one of the common drugs used in clinical practice in the management of traveler’s diarrhea, irritable bowel syndrome (IBS), and hepaticencephalopathy. Hyponatremia is one of the rare side effects of this drug. We hereby present the case of a middle-aged woman who was a known caseof IBS: Diarrhea predominant who developed symptoms of hyponatremia after a short duration of rifaximin treatment, no other cause of hyponatremiawas found on evaluation, so we suspect this as a rare side effect of rifaximin therapy.Keywords: Rifaximin, Hyponatremia, Irritable bowel syndrome.

Sign in / Sign up

Export Citation Format

Share Document